Literature DB >> 12581269

Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem.

C N Dang1, Y D M Prasad, A J M Boulton, E B Jude.   

Abstract

AIMS: To determine if there has been a change in the prevalence of pathogenic organisms in foot ulcers in diabetic patients in 2001 compared with our previous study in 1998.
METHODS: A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients attending the outpatient clinic in the Manchester Foot Hospital over a twelve-month period. A total of 63 patients with positive wound swabs were identified.
RESULTS: Gram-positive aerobic bacteria still predominate (84.2%) and the commonest single isolate remains Staphylococcus aureus (79.0%) which is higher than we previously reported. MRSA was isolated in 30.2% of the patients which is almost double the proportion of MRSA-affected patients three years ago. This did not appear to be related to prior antibiotic usage. There was no increase in hospitalisation because of MRSA infection.
CONCLUSIONS: The problem of MRSA continues to increase despite the precautions taken to prevent MRSA spread. There is a need for a multi-centre study looking into the prevalence of MRSA in diabetic foot ulcer and how this can be reduced in the diabetic foot clinic.

Entities:  

Mesh:

Year:  2003        PMID: 12581269     DOI: 10.1046/j.1464-5491.2003.00860.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  48 in total

Review 1.  Diabetic foot infections: stepwise medical and surgical management.

Authors:  David G Armstrong; Benjamin A Lipsky
Journal:  Int Wound J       Date:  2004-06       Impact factor: 3.315

2.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

Review 3.  The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey.

Authors:  M Hatipoglu; M Mutluoglu; G Uzun; E Karabacak; V Turhan; B A Lipsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

4.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.

Authors:  A Sotto; J-L Richard; C Combescure; N Jourdan; S Schuldiner; N Bouziges; J-P Lavigne
Journal:  Diabetologia       Date:  2010-06-23       Impact factor: 10.122

Review 6.  Management of osteomyelitis of the foot in diabetes mellitus.

Authors:  Fran Game
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 7.  MRSA and diabetic foot wounds: contaminating or infecting organisms?

Authors:  Frank L Bowling; Edward B Jude; Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

Review 8.  The treatment of diabetic foot infections: focus on ertapenem.

Authors:  Michael Edmonds
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

Review 9.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Management of diabetic foot infections in an era of increasing microbial resistance.

Authors:  Sandra Bliss Nelson
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.